Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/3/2025

Cannabis Use in LQTS1 on Beta-Blockers: Risk Assessment

Introduction to LQTS1 Risk Factors

  • The American College of Cardiology recommends that LQTS1 patients avoid substances that trigger catecholamine surges and elevated heart rates, as these can provoke life-threatening arrhythmias, with beta-blockers reducing adverse cardiac events by >95% in LQTS1 patients 1, 2

Physiological Mechanisms of Concern

  • Cannabis acutely increases heart rate and sympathetic tone, creating conditions that trigger ventricular arrhythmias in LQTS1 patients, according to the American College of Cardiology 3
  • LQTS1 involves abnormal potassium channel function that impedes normal protective shortening of ventricular repolarization during fast heart rates, as noted by the American College of Cardiology 3

Beta-Blocker Protection and Limitations

  • Beta-blockers provide 67-95% risk reduction in LQTS1 patients, depending on specific characteristics, with the American College of Cardiology recommending their use 1, 2
  • QT-prolonging substances, including some medications, are classified as Class III: Harm in LQTS management guidelines by the American College of Cardiology 1, 2, 4

Critical Context About Baseline Risk and Substance Avoidance

  • Any substance that increases sympathetic tone or heart rate works against beta-blocker therapy in LQTS1 patients, according to the American College of Cardiology and European Heart Journal 3, 5, 7
  • The American Heart Association and European Heart Journal suggest that patients should avoid all substances that increase catecholamine release, including energy drinks, stimulants, and sympathomimetic drugs 3, 5, 7

Management and Prevention Strategies

  • The American College of Cardiology and European Heart Journal recommend ensuring adequate beta-blocker dosing, with nadolol as the preferred medication, and undergoing exercise stress testing to confirm QTc response to exertion and verify adequate beta-blockade 5, 6
  • Patients should strictly avoid all QT-prolonging medications and check www.crediblemeds.org before taking any new substance, as advised by the American College of Cardiology and European Heart Journal 1, 2, 5
  • Maintaining normal electrolytes, including potassium and magnesium, at all times is crucial, as abnormalities can precipitate arrhythmias, according to the European Heart Journal 5, 7

REFERENCES

3

Management of Long QT Syndrome in Adolescents [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Management of Long QT Syndrome [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

7

Nadolol Dosing for Long QT Syndrome [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025